Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 153 of the 166 references it cites were found in a registry or an index; 29 of the 64 sources its claims cite were checked for support.

Pathophysiological Aspects of Alcohol Metabolism in the Liver

Open access
Hyun, Jeongeun, Han, Jinsol, Lee, Chanbin, Yoon, Myunghee, Jung, Youngmi · 2021 · International Journal of Molecular Sciences

Abstract

Alcoholic liver disease (ALD) is a globally prevalent chronic liver disease caused by chronic or binge consumption of alcohol. The liver is the major organ that metabolizes alcohol; therefore, it is particularly sensitive to alcohol intake. Metabolites and byproducts generated during alcohol metabolism cause liver damage, leading to ALD via several mechanisms, such as impairing lipid metabolism, intensifying inflammatory reactions, and inducing fibrosis. Despite the severity of ALD, the development of novel treatments has been hampered by the lack of animal models that fully mimic human ALD. To overcome the current limitations of ALD studies and therapy development, it is necessary to understand the molecular mechanisms underlying alcohol-induced liver injury. Hence, to provide insights into the progression of ALD, this review examines previous studies conducted on alcohol metabolism in the liver. There is a particular focus on the occurrence of ALD caused by hepatotoxicity originating from alcohol metabolism.

Overview

CoChat Summary

TL;DR

This paper is a narrative review of how alcohol metabolism in the liver drives alcoholic liver disease (ALD), with emphasis on toxic oxidative metabolites such as acetaldehyde and ROS. It argues that these metabolites promote steatosis, inflammation, fibrosis, and liver cancer, and that better human-relevant models are needed to develop therapies.

Key findings

  • Alcohol is mainly metabolized in the liver by the oxidative pathway: alcohol dehydrogenase (ADH) converts alcohol to acetaldehyde, and aldehyde dehydrogenase (ALDH) converts acetaldehyde to acetate; more than 90% of absorbed alcohol is transported to the liver, and less than 10% is excreted in breath, sweat, and urine.
  • The paper states that alcoholic fatty liver is observed in up to 90% of heavy drinkers, and that excessive alcohol consumption leads to a 3- to 10-fold increase in hepatocellular carcinoma (HCC) risk and accounts for 30% of HCC cases worldwide.
  • Chronic alcohol exposure disrupts the gut barrier, promotes lipopolysaccharide translocation, and activates Kupffer cells and the TLR4/MAPK/NF-κB axis; the paper also reports that TLR4 knockout mice were resistant to alcohol-induced hepatic steatosis.
  • Alcohol metabolism-derived acetaldehyde and ROS promote fibrosis and cancer by damaging DNA/proteins, activating hepatic stellate cells, and impairing repair; the paper notes that ALDH2 deficiency is associated with higher liver-cancer risk in heavy drinkers, and that 30–40% of the Asian population has ALDH2 deficiency.

Methods

  • Narrative review of previous studies on alcohol metabolism in the liver and its role in ALD pathogenesis; not an original experimental study.
  • The paper synthesizes findings from human studies, rodent studies, and in vitro/ex vivo models of ALD.
  • It summarizes mechanisms across alcohol metabolism, lipid accumulation, immune dysregulation, fibrosis, carcinogenesis, and model systems used for ALD research.

Limitations

  • Stated in the paper: there is a lack of ALD patient samples and reliable animal models that reflect human ALD, which hampers understanding and therapy development.
  • Stated in the paper: many candidate therapies tested in animal models are controversial or not proven clinically, and the paper notes that no FDA-approved drug exists for ALD.
  • Evident from the text: because this is a review, it does not present new primary data or a formal systematic search/selection protocol, so its conclusions depend on the studies it chose to summarize.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms22115717

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Scheme for alcohol metabolism in the liver. In the liver, alcohol is metabolized by the oxidative and non-oxidative pathway. In the oxidative pathway, the major pathway of alcohol digestion, alcohol is oxidized to acetaldehyde by various enzymes including alcohol dehydrogenase (ADH), cytochrome P450 2E1 (CYP2E1), and catalase. Then, acetaldehyde is broken down into acetate, which is excreted out of the liver. Especially when excessive alcohol is consumed, CYP2E1 is activated and promotes formation of reactive oxygen species (ROS). The non-oxidative pathway accounts for a small amount of alcohol metabolism. Various enzymes nonoxidatively conjugates alcohol with different endogenous metabolites, producing fatty acid ethyl ester (FAEE), phosphatidylethanol (PEth), ethyl glucuronide (EtG), and ethyl sulfate (EtS). The byproducts generated during alcohol metabolism injure the liver by increasing lipid accumulation, inflammation, and fibrosis. Especially, acetaldehyde, the first metabolite of alcohol metabolism, is well known for toxic compounds. ROS, which are generated by activation of CYP2E1, are also considered as one of the major contributors of liver damage. In addition, acetate and non-oxidative metabolites are known to damage the liver.
Figure 1 Scheme for alcohol metabolism in the liver. In the liver, alcohol is metabolized by the oxidative and non-oxidative pathway. In the oxidative pathway, the major pathway of alcohol digestion, alcohol is oxidized to acetaldehyde by various enzymes including alcohol dehydrogenase (ADH), cytochrome P450 2E1 (CYP2E1), and catalase. Then, acetaldehyde is broken down into acetate, which is excreted out of the liver. Especially when excessive alcohol is consumed, CYP2E1 is activated and promotes formation of reactive oxygen species (ROS). The non-oxidative pathway accounts for a small amount of alcohol metabolism. Various enzymes nonoxidatively conjugates alcohol with different endogenous metabolites, producing fatty acid ethyl ester (FAEE), phosphatidylethanol (PEth), ethyl glucuronide (EtG), and ethyl sulfate (EtS). The byproducts generated during alcohol metabolism injure the liver by increasing lipid accumulation, inflammation, and fibrosis. Especially, acetaldehyde, the first metabolite of alcohol metabolism, is well known for toxic compounds. ROS, which are generated by activation of CYP2E1, are also considered as one of the major contributors of liver damage. In addition, acetate and non-oxidative metabolites are known to damage the liver.CC BY · PubMed Central
Figure 2 Harmful effects of acetaldehyde on ALD. Acetaldehyde, one of the oxidative ethanol-derived metabolites, exerts a broad spectrum of damage to the liver, ranging from lipid accumulation in hepatocytes to inflammation, fibrosis, and carcinogenesis. The hepatocytes accumulate lipids by the lipid oversupply (increase of fatty acid (FA) uptake to the liver and de novo lipogenesis in the liver) and/or the impaired pathway of lipid clearance (decrease of mitochondrial β-oxidation and secretion of excessive lipids in very-low density lipoprotein (VLDL)). In addition, acetaldehyde activates Kupffer cells, the liver-resident macrophage, to release reactive oxygen species (ROS) and cytokines that recruit other immune cells. When exposed to acetaldehyde, Kupffer cells activate the toll-like receptor 4 (TLR4)-mediated nuclear factor (NF)-κB signaling pathway, triggering inflammatory responses. The acetaldehyde-protein adducts promote the collagen production by activated hepatic stellate cells (HSCs) via the protein kinase C (PKC) and the TGF-β signaling pathway. ROS-mediated oxidative stress also accelerates liver fibrosis. Moreover, protein and DNA adducts with acetaldehyde cause hepatic carcinogenesis. They weaken DNA integrity and interfere with DNA repair system, increasing carcinogenic DNA mutation. Genetic variations in the alcohol-metabolizing enzymes, such as acetaldehyde dehydrogenase (ALDH)2*2 and alcohol dehydrogenase (ADH)1C*1 alleles, suppress the activity of the enzymes, enhancing the amount of acetaldehyde.
Figure 2 Harmful effects of acetaldehyde on ALD. Acetaldehyde, one of the oxidative ethanol-derived metabolites, exerts a broad spectrum of damage to the liver, ranging from lipid accumulation in hepatocytes to inflammation, fibrosis, and carcinogenesis. The hepatocytes accumulate lipids by the lipid oversupply (increase of fatty acid (FA) uptake to the liver and de novo lipogenesis in the liver) and/or the impaired pathway of lipid clearance (decrease of mitochondrial β-oxidation and secretion of excessive lipids in very-low density lipoprotein (VLDL)). In addition, acetaldehyde activates Kupffer cells, the liver-resident macrophage, to release reactive oxygen species (ROS) and cytokines that recruit other immune cells. When exposed to acetaldehyde, Kupffer cells activate the toll-like receptor 4 (TLR4)-mediated nuclear factor (NF)-κB signaling pathway, triggering inflammatory responses. The acetaldehyde-protein adducts promote the collagen production by activated hepatic stellate cells (HSCs) via the protein kinase C (PKC) and the TGF-β signaling pathway. ROS-mediated oxidative stress also accelerates liver fibrosis. Moreover, protein and DNA adducts with acetaldehyde cause hepatic carcinogenesis. They weaken DNA integrity and interfere with DNA repair system, increasing carcinogenic DNA mutation. Genetic variations in the alcohol-metabolizing enzymes, such as acetaldehyde dehydrogenase (ALDH)2*2 and alcohol dehydrogenase (ADH)1C*1 alleles, suppress the activity of the enzymes, enhancing the amount of acetaldehyde.CC BY · PubMed Central
Figure 3 Cellular interactions during the pathogenesis of ALD. Acetaldehyde (Ac) produced by hepatocytes during ethanol oxidation activates Kupffer cells to release reactive oxygen species (ROS) which triggers inflammatory responses in a TLR4/NF-κB-dependent manner and leads to massive hepatocyte death. In vitro, Ac secreted from hepatocytes enters into the hepatic stellate cells (HSCs), promotes the binding of Ac-responsive transcription factors (AcR-TFs) to the acetaldehyde-responsive element (AcRE) in the promoter region of type I collagen (Col) genes to onset of transcription. Ac also activates HSCs via other pro-fibrogenic mechanisms, increasing deposition of extracellular matrix (ECM) proteins. Anti-fibrotic effect of natural killer (NK) cells that are cytotoxic to activated HSCs is inhibited by chronic alcohol consumption.
Figure 3 Cellular interactions during the pathogenesis of ALD. Acetaldehyde (Ac) produced by hepatocytes during ethanol oxidation activates Kupffer cells to release reactive oxygen species (ROS) which triggers inflammatory responses in a TLR4/NF-κB-dependent manner and leads to massive hepatocyte death. In vitro, Ac secreted from hepatocytes enters into the hepatic stellate cells (HSCs), promotes the binding of Ac-responsive transcription factors (AcR-TFs) to the acetaldehyde-responsive element (AcRE) in the promoter region of type I collagen (Col) genes to onset of transcription. Ac also activates HSCs via other pro-fibrogenic mechanisms, increasing deposition of extracellular matrix (ECM) proteins. Anti-fibrotic effect of natural killer (NK) cells that are cytotoxic to activated HSCs is inhibited by chronic alcohol consumption.CC BY · PubMed Central

Verification

Claims the paper makes

20 Valid · 1 Not valid · 9 Not checked · 6 Own results and interpretations

19 more claims · 9 with their cited sources checked

Create a free account to see all 36 claims and to verify the 6 references still open.

See all claims — free account
  • Probably not a substantial claim. 3
  • It may state two separate claims as one. 9
  • Borderline: one of the tests for a substantial claim is unclear. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 166 references

Research works printed but not linked: 1

  1. Parkkila, 1998, Early alcoholic liver injury: Formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A, Alcohol Clin. Exp. Res., 22, 2118

Cited by

See all 324

Metadata

Authors
Hyun, J., Han, J., Lee, C., Yoon, M., & Jung, Y.
Affiliations
  • Dankook University (KR)
  • Pusan National University (KR)
  • Department of Surgery, Division of Hepatobiliary and Pancreas Surgery, Biomedical Research Institute, Pusan National University, Pusan 46241, Korea
Corresponding author
Jung, Youngmi
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-05-27
Volume
22
Issue
11
Pages
5717
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3164074301
Cited by
324
References
166
Citations by year
2026: 56 · 2025: 93 · 2024: 74 · 2023: 66 · 2022: 28 · 2021: 6
FWCI
7.62
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research Foundation of Korea (2021R1C1C1003904)
  • Biomedical Research Institute Grant of Pusan National University Hospital (20200216)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
alcoholic liver disease, alcohol metabolism, hepatotoxicity, liver injury, lipid metabolism, inflammation, liver fibrosis, animal models of alcoholism
MeSH terms
Ethanol, Animals, Disease Susceptibility, Humans, Immune System, Liver, Liver Cirrhosis, Liver Diseases, Alcoholic, Liver Neoplasms, Inactivation, Metabolic, Oxidation-Reduction, Sensitivity and Specificity, Reactive Oxygen Species, Hepatocytes, Lipid Metabolism, Metabolic Networks and Pathways, Immunomodulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pathophysiological Aspects of Alcohol Metabolism in the Liver. https://app.cochat.ai/papers/10.3390/ijms22115717
The paper
Hyun, J., Han, J., Lee, C., Yoon, M., & Jung, Y. (2021). Pathophysiological Aspects of Alcohol Metabolism in the Liver. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22115717

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.